Isolated tumor cells in the bone marrow (ITC-BM) of breast cancer patients before and after anthracyclin based therapy: influenced by the HER2- and Topoisomerase IIα-status of the primary tumor?

This publication has 33 references indexed in Scilit:

• Isolated Tumor Cells in Bone Marrow Three Years after Diagnosis in Disease-Free Breast Cancer Patients Predict Unfavorable Clinical Outcome1
  Clinical Cancer Research, 2004
• International Expert Panel on the Use of Primary (Preoperative) Systemic Treatment of Operable Breast Cancer: Review and Recommendations
  Journal of Clinical Oncology, 2003
• Topoisomerase II-α (topoII) and HER2 amplification in breast cancers and response to preoperative doxorubicin chemotherapy
  European Journal Of Cancer, 2003
• Cellular roles of DNA topoisomerases: a molecular perspective
  Nature Reviews Molecular Cell Biology, 2002
• c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patients
  International Journal of Cancer, 2000
• HER-2/neu assessment in breast cancer by immunohistochemistry and fluorescence in situ hybridization: Comparison of results and correlation with survival
  Molecular Diagnosis, 2000
• Topoisomerase IIα Expression in Breast Cancer: Correlation with Outcome Variables
  Laboratory Investigation, 2000
• Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast Cancer
  New England Journal of Medicine, 2000
• HER-2/neu Assessment in Breast Cancer by Immunohistochemistry and Fluorescence In Situ Hybridization: Comparison of Results and Correlation With Survival
  Molecular Diagnosis, 2000
• Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma Cells
  JNCI Journal of the National Cancer Institute, 1993